An integrin-targeted non-viral vector for pulmonary gene therapy.
about
DNA as therapeutics; an update.Gene delivery from supercharged coiled-coil protein and cationic lipid hybrid complex.Nebulisation of receptor-targeted nanocomplexes for gene delivery to the airway epithelium.Cationic lipid-mediated transfection in vitro and in vivo (review).Targeted gene delivery to the lung.Non-viral vectors in cystic fibrosis gene therapy: recent developments and future prospects.Lipid mixing between lipoplexes and plasma lipoproteins is a major barrier for intravenous transfection mediated by cationic lipids.Specific CEA-producing colorectal carcinoma cell killing with recombinant adenoviral vector containing cytosine deaminase gene.Non-viral, integrin-mediated gene transfer into fibroblasts from patients with lysosomal storage diseases.Enhanced gene delivery to human airway epithelial cells using an integrin-targeting lipoplex.A recombinant chimeric epidermal growth factor-like module with high binding affinity for integrins.Characterisation of LMD virus-like nanoparticles self-assembled from cationic liposomes, adenovirus core peptide mu and plasmid DNA.Escape from the matrix: multiple mechanisms for fibroblast activation in pulmonary fibrosis.Repeated intrathecal administration of plasmid DNA complexed with polyethylene glycol-grafted polyethylenimine led to prolonged transgene expression in the spinal cord.DNA delivery from an intravascular stent with a denatured collagen-polylactic-polyglycolic acid-controlled release coating: mechanisms of enhanced transfection.Analysis and optimization of the cationic lipid component of a lipid/peptide vector formulation for enhanced transfection in vitro and in vivo.
P2860
Q33836499-F5330090-B56F-49A8-9841-26F4008F3FE0Q33904910-5EE767D3-5A13-4930-ABE8-60619EB4B8A9Q34064665-CBF2A56B-A3F5-4022-ABBB-4D599107EC5DQ34313548-248867F3-2268-4971-898D-D34093029DB5Q37486747-FFBF8A3A-FA0E-4706-A925-0AB70CC43101Q37526991-26F2FDA4-7D36-430B-860E-0E28008B1E34Q40468394-D263C504-2534-40D2-B40A-DE250DAFFCE6Q40741120-69B0DE1F-CB27-4A6B-ABF1-620FB55BBC43Q40774720-3F510B68-B427-4F95-B6D1-06822AD9711CQ40810576-740186AF-595C-4447-9D4E-4445A7715948Q42595579-F6528FAB-CA65-4332-BBC3-F2BF934354C3Q42815972-8EEB8C64-5699-4A07-8FFA-D2B1099CBD13Q43180245-245DF109-7384-461F-B28C-64076F4A170DQ45863310-5E935F23-8A09-4D57-A56F-F245A63FCB74Q45864360-1E2E3BBD-B548-409A-A123-48D82D92B237Q45864381-ACEBE24D-30F4-472C-8E2B-31875D5237FC
P2860
An integrin-targeted non-viral vector for pulmonary gene therapy.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
An integrin-targeted non-viral vector for pulmonary gene therapy.
@en
An integrin-targeted non-viral vector for pulmonary gene therapy.
@nl
type
label
An integrin-targeted non-viral vector for pulmonary gene therapy.
@en
An integrin-targeted non-viral vector for pulmonary gene therapy.
@nl
prefLabel
An integrin-targeted non-viral vector for pulmonary gene therapy.
@en
An integrin-targeted non-viral vector for pulmonary gene therapy.
@nl
P2093
P2860
P356
P1433
P1476
An integrin-targeted non-viral vector for pulmonary gene therapy.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.GT.3301095
P577
2000-03-01T00:00:00Z
P5875
P6179
1042502651